Gau-Algesheim, Germany

Walter Lösel

This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Ingelheim Gmbh. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter Lösel. Retrieved from https://idiyas.com/inventor/walter-landoumlsel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Walter Lösel: Innovator in Pharmaceutical Preparations

Introduction

Walter Lösel is a notable inventor based in Gau-Algesheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on dihydropyridines. With a total of 2 patents to his name, Lösel continues to impact the pharmaceutical industry.

Latest Patents

Lösel's latest patents include the development of annelated dihydropyridines and their use in preparing pharmaceutical preparations. This innovative compound, described by a specific formula, showcases his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Walter Lösel is associated with Boehringer Ingelheim GmbH, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to focus on research and development, contributing to the creation of effective pharmaceutical solutions.

Collaborations

Lösel has collaborated with esteemed colleagues such as Otto Roos and Dietrich Arndts. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their shared field.

Conclusion

Walter Lösel's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…